Exact Mass: 392.0874

Exact Mass Matches: 392.0874

Found 48 metabolites which its exact mass value is equals to given mass value 392.0874, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Actos

2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-ETHYL-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, MONOHYDROCHLORIDE, (+/-)-

C19H20N2O3S.HCl (392.0961)


Pioglitazone hydrochloride is an aromatic ether. Pioglitazone Hydrochloride is the hydrochloride salt of an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation. (NCI05) A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS. See also: Pioglitazone (has active moiety); Glimepiride; Pioglitazone Hydrochloride (component of); Alogliptin Benzoate; Pioglitazone Hydrochloride (component of). C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.

   

Hosloppin

5-Hydroxy-6- (5-hydroxy-6-methyl-4-oxo-4H-pyran-3-yl) -7-methoxy-2-phenyl-4H-1-benzopyran-4-one

C22H16O7 (392.0896)


   

8-C-p-Hydroxybenzylkaempferol

3,5,7,4-Tetrahydroxy-8- (4-hydroxyphenylmethyl) flavone

C22H16O7 (392.0896)


   
   
   
   
   
   

Bisanhydrorutilantinone

Bisanhydrorutilantinone

C22H16O7 (392.0896)


   
   

CHEMBL225917

CHEMBL225917

C22H16O7 (392.0896)


   

8-p-Hydroxybenzylluteolin

8-p-Hydroxybenzylluteolin

C22H16O7 (392.0896)


   

(+)-acetodalmanol A

(+)-acetodalmanol A

C22H16O7 (392.0896)


   

4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

4,5,7-trihydroxy-6-(3,4-dihydroxybenzyl)flavone|6-(3,4-dihydroxybenzyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one

C22H16O7 (392.0896)


   

phelliribsin A

phelliribsin A

C22H16O7 (392.0896)


   

Resistoflavine

Resistoflavine

C22H16O7 (392.0896)


   

Jusmicranthin ethyl ether

Jusmicranthin ethyl ether

C22H16O7 (392.0896)


Annotation level-1

   

Bisanhydrorutilantinone_major

Bisanhydrorutilantinone_major

C22H16O7 (392.0896)


   

Abu-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-ethoxy-4-nitrobenzamido)propanoic acid

C18H17ClN2O6 (392.0775)


   

His-Asp-OH

(S)-2-(3-(2-(1H-imidazol-4-yl)ethoxy)-4-nitrobenzamido)pentanedioic acid

C16H16N4O8 (392.0968)


   

Phe4Cl-Abu-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)pentanoic acid

C18H17ClN2O6 (392.0775)


   
   

Parecoxib sodiuM

Parecoxib sodiuM

C19H17N2NaO4S (392.0807)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents

   

METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

METHYL 1-(4-(TRIFLUOROMETHYL)PHENYL)-5-(4-(METHYLTHIO)PHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C19H15F3N2O2S (392.0806)


   

N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide

N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-p-toluenesulphonamide

C21H16N2O4S (392.0831)


   

((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

((2R,3R,4R,5R)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

C20H18ClFO5 (392.0827)


   

((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

((2R,3R,4R,5S)-3-(benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate

C20H18ClFO5 (392.0827)


   

2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-

2-Propanesulfonamide, N-((3S,4S)-4-(4-(5-cyano-2-thienyl)phenoxy)tetrahydro-3-furanyl)-

C18H20N2O4S2 (392.0864)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM[1].

   

Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate

Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate

C21H16N2O4S (392.0831)


   

2-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methylthio]-6-phenyl-1H-pyrimidin-4-one

2-[[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methylthio]-6-phenyl-1H-pyrimidin-4-one

C20H16N4O3S (392.0943)


   

Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate

Methyl 6,11-dihydro-6,11-dioxo-2-ethyl-5,7,9-trihydroxy-1-naphthacenecarboxylate

C22H16O7 (392.0896)


   

Pioglitazone Hydrochloride

Pioglitazone Hydrochloride

C19H21ClN2O3S (392.0961)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.

   

2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide

2-[[5,6-bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-N-(3-methylphenyl)acetamide

C20H16N4O3S (392.0943)


   

2-(1,4-dioxo-3H-phthalazin-2-yl)-N-(5-methyl-4-phenyl-2-thiazolyl)acetamide

2-(1,4-dioxo-3H-phthalazin-2-yl)-N-(5-methyl-4-phenyl-2-thiazolyl)acetamide

C20H16N4O3S (392.0943)


   

(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate

(4-oxopyrimido[2,1-b][1,3]benzothiazol-2-yl)methyl (E)-3-(4-methoxyphenyl)prop-2-enoate

C21H16N2O4S (392.0831)


   

[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate

[4-[3-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]oxiran-2-yl]phenyl] hydrogen sulate

C19H20O7S (392.093)


   

2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one

2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one

C22H16O7 (392.0896)


   

2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one

2'-acetyl-5-[2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one

C22H16O7 (392.0896)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(4-hydroxyphenyl)methyl]chromen-4-one

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(4-hydroxyphenyl)methyl]chromen-4-one

C22H16O7 (392.0896)


   

2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione

2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione

C22H16O7 (392.0896)


   

(17r)-2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione

(17r)-2,12,14,17-tetrahydroxy-4,9,9-trimethylpentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1,3,5(18),7,11,13,15-heptaene-6,10,19-trione

C22H16O7 (392.0896)


   

(17s,18r)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

(17s,18r)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

C22H16O7 (392.0896)


   

methyl 2-ethyl-5,7,10-trihydroxy-6,11-dioxotetracene-1-carboxylate

methyl 2-ethyl-5,7,10-trihydroxy-6,11-dioxotetracene-1-carboxylate

C22H16O7 (392.0896)


   

(2r)-2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one

(2r)-2,4,7-trihydroxy-2-(2-oxopropyl)-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-3-one

C22H16O7 (392.0896)


   

2'-acetyl-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one

2'-acetyl-5-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-5',6'-dihydroxyspiro[furan-2,1'-inden]-3-one

C22H16O7 (392.0896)


   

(17r,18s)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

(17r,18s)-13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

C22H16O7 (392.0896)


   

6-[(3,4-dihydroxyphenyl)methyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one

6-[(3,4-dihydroxyphenyl)methyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one

C22H16O7 (392.0896)


   

13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

13,15,18-trihydroxy-14-(1-hydroxyethylidene)-17-methyl-8-oxapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-1,4,6,9,12,15,19-heptaene-3,11-dione

C22H16O7 (392.0896)